Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's Infanrix/Hib vaccine in children; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Pertussis
• Tetanus

Drugs mentioned

• Infanrix/Hib

Snippet

Sponsor: GlaxoSmithKline | Conditions: Acellular Pertussis, Diphtheria | Phase 3 | Status: COMPLETED | Results posted: 2009-08-26